CRF Health, a provider of electronic clinical outcomes assessment (eCOA)solutions for the life sciences industry, has acquired remote patient monitoring-focused startup Entra Health. Financial details of the acquisition were not disclosed.
For CRF Health, the acquisition will help the company expand its footprint in wireless medical and wellness devices market. Additionally, it will help strengthen its integration with its eCOA technologies to establish a complete network of solutions to collect, manage, and analyze biometric and clinical data.
Founded in 2002, Entra’s FDA-cleared MyHealthPoint solution provides an integrated, secure and scalable platform for collecting, transmitting and analyzing biometric data across a variety of wellness and clinical devices, fitness and clinical applications, for payers and providers, technology partners, as well as clinical researchers alike.
The San-Diego based company also offers MyGlucoHealth wireless meter, an integrated Bluetooth-enabled blood glucose meter for diabetic patients; and MyGlucoHealth test strips that employ a biosensor technology composed of electrochemical components that require only an extremely small volume of blood for accurate measurement.
“We see tremendous promise in the opportunities the acquisition of Entra Health brings, as well as the contribution this makes to our continued growth strategy as we broaden CRF Health’s reach across the industry. Combining CRF Health’s extensive global eCOA and electronic informed consent expertise with Entra Health’s clinical platform, medical device innovation and regulatory insight, we can now offer selection, production and delivery of devices together with the complete integration of data,” said CRF Health’s CEO, Rachael Wyllie in a statement. CRF Health is now positioned to build upon our patient-centric approach, bringing new levels of connectivity to devices and cloud services much in demand from our customers.”